Showing 5181-5190 of 23238 results for "".
A Closer Look at OX40 Pathway Modulation
https://reachmd.com/programs/practical-dermatology-type-ii-inflammation-journal-club/a-closer-look-at-ox40-pathway-modulation/50890/Walter Liszewski, MD, talks with Matthew Zirwas, MD, about the potential therapeutic applications, based on the article “Targeting the OX40-OX40L pathway: A new era in atopic dermatitis management by T-cell rebalancing,”1 as well as the risks of therapies targeting the OX40 pathway.Uncovering the Disease Burden of Untreated Pediatric TK2 Deficiency
https://reachmd.com/programs/clinicians-roundtable/disease-burden-of-untreated-pediatric-tk2-deficiency/37634/How fast does thymidine kinase 2 deficiency (TK2d) progress without intervention? That’s the question explored by the largest dataset to date on untreated pediatric-onset TK2d, and the results reveal a median survival of just 2.6 years from symptom onset. Additionally, more than 80% lost at least onPrioritizing Quality of Life in CRC: Key Surgical Considerations
https://reachmd.com/programs/on-the-frontlines-of-colorectal-cancer/quality-of-life-crc-surgery/49174/Surgical teams are redefining care for patients with colorectal cancer by prioritizing not just survival, but also life after surgery. Ryan Quigley sits down with Drs. Thomas Cataldo and Sowmya Sharma from Beth Israel Deaconess Medical Center as they share real-world strategies that integrate qualitTracking Tumor Resistance in Metastatic Breast Cancer Care
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/tracking-tumor-resistance-metastatic-breast-cancer/48709/Tumor evolution and therapeutic resistance remain central challenges in metastatic breast cancer care, and as treatment strategies advance, so does our need to monitor disease progression in more dynamic and precise ways. Joining Ryan Quigley to discuss how resistance develops under treatment pressuStrategies for Addressing Complications in Retinal Vein Occlusion
https://reachmd.com/programs/eye-on-ocular-health/strategies-for-addressing-complications-in-retinal-vein-occlusion/37666/Patients with retinal vein occlusion can lose their vision for three reasons: ischemia, neovascularization, and, most commonly, macular edema. As a result, understanding how to effectively manage each of these challenges—particularly macular edema—is crucial. Join Dr. Lisa Schocket as she discussesHow Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
https://reachmd.com/programs/neurofrontiers/how-diagnostic-delays-in-gmg-impact-disease-severity-outcomes-and-quality-of-life/35492/The symptom variability, prolonged asymptomatic periods, and inconsistent presentations of generalized myasthenia gravis (gMG) often lead to significant diagnostic delays and misdiagnoses. Based on recent studies, these delays then correlate with increased disease severity, longer time to symptom coAdapting Our Exercise Talk: Key Tips on Counseling Patients on Exercise
https://reachmd.com/programs/diabetes-discourse/adapting-our-exercise-talk-key-tips-on-counseling-patients-on-exercise/14633/How can we help our patients incorporate exercise into their daily lives? Find out.Strategies for Combating COVID-19 Conspiracies & Myths
https://reachmd.com/programs/covid-19-frontlines/strategies-for-combating-covid-19-conspiracies-myths/13195/The rapid spread of misinformation is one of the biggest threats to combating the COVID-19 pandemic. Fortunately, these strategies can help.Investigating Type 1 Diabetes & Its Chronic Impacts
https://reachmd.com/programs/diabetes-discourse/investigating-type-1-diabetes-and-its-chronic-impacts/12232/How does type 1 diabetes impact the body over time?Natural Sexual Aphrodisiacs: The Good, The Bad, and The Deadly
https://reachmd.com/programs/sexmed/natural-sexual-aphrodisiacs-good-bad-deadly/8043/Many supplements are sold over the counter to enhance sexual function. But surprising numbers of foods and herbs cause ranges of serious side effects.